3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Completed
3
Unknown
1
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Breast Neoplasms
14
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Lung Neoplasms
7
Melanoma
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplastic Cells, Circulating
4
Hematologic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioblastoma
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Liver Diseases
2
Kidney Neoplasms
2
Glioma
2
Fibrosis
2
Interventions
Cyclophosphamide
12
Etoposide
10
Doxorubicin
9
Brentuximab Vedotin
8
fludarabine phosphate
7
Vinblastine
7
Dacarbazine
7
Bleomycin
7
Vincristine
6
Melphalan
6
camrelizumab
5
Radiotherapy
5
Nivolumab
5
Mycophenolic Acid
5
Decitabine
5
pembrolizumab
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Gemcitabine
4
Filgrastim
4
Cytarabine
4
Cyclosporine
4
Busulfan
4
Bendamustine Hydrochloride
4
ABVD protocol
4
Tacrolimus
3
Prednisone
3
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Ifosfamide
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hodgkin Disease
×
Blood Specimen Collection
×
Clear all
NCT05735704
2025-03-26
SANGUINE
JaxBio Ltd
Unknown
3,000 enrolled